• Abstract and Figures
• Public Full-text

SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Mindray Building, Keji 12th Road South, High-tech Industrial Park, Nanshan, Shenzhen 518057, P.R. China Tel: +86 755 26582888 Fax: +86 755 26582680 Website: www.mindray.com P/N:BROCHURES-450305-201004 Mindray is listed on the NYSE under the ticker “MR” 2010 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. All rights reserved. VISION We will make better healthcare solutions more accessible to humanity. MISSION Improve healthcare by optimizing and sharing medical technologies with the world. CONTENTS Shenzhen is a beautiful coastal city in South China, and is one of the “31 Places to Go in 2010” listed by The New York Times. Shenzhen borders Hong Kong and covers an area of 1,953 km² (754 sq. miles) with over ten million (2008 est.) inhabitants. Profile 1 After becoming the first special Chinese economic zone in Global Expansion 3 1980, it grew into a prosperous metropolis with an astounding annual growth rate of 15% , boasting the highest Customer Focus 5 GDP per capita in mainland China. This young and vibrant city R&D 7 is impressive not only in terms of growth, but also in the Products 9 strength of its industries like hi-tech, finance, foreign trade, Manufacturing & Quality 15 exports and shipping. Our Services 17 The hi-tech industry contributes nearly one third to Corporate Citizenship 19 Shenzhen's GDP, firmly making the city the “Silicon Valley” of Milestones 21 China. Innovation is the industry’s growth engine, and the greatest innovations happening in China can be found in Shenzhen's Hi-Tech Park where Mindray is headquartered. Profile Who We Are Mindray was founded in 1991 with the goal of delivering Canada, France, India, Indonesia, Italy, Mexico, the high-quality, competitively priced medical devices to make Netherlands, Russia, Turkey, the UK and the USA. Additionally, healthcare more accessible and affordable around the world. the acquisition of Datascope Corporation's patient In 2006, Mindray listed on the New York Stock Exchange and is monitoring business has added significant direct sales and now a leading developer, manufacturer and marketer of service capabilities on the ground in the U.S. and Western medical devices worldwide. Europe. The company has three well-established business segments: Mindray has a global R&D network with research centers in Patient Monitoring and Life Support Products, In-Vitro Shenzhen, Beijing, Nanjing, Seattle, New Jersey and Diagnostic Products and Medical Imaging Systems. Health Stockholm. Over 1,400 engineers are employed in the network care facilities equipped with Mindray's products can be found and approximately 10% of total revenue has been consistently in over 190 countries and regions. A sound distribution and invested into R&D each year. An average of eight new products service network has been formed with 29 branch offices have annually been introduced to the market over the past throughout China, and overseas subsidiaries in Brazil, seven years. A Public Listed Company On September 26, 2006 Mindray was successfully listed on the New York Stock Exchange(NYSE), the largest exchange in the world by dollar volume. The NYSE listing not only recognizes our efforts and excellence in improving corporate operations and providing quality products for the past 15 years, but also gives M indray a global presence along with new opportunities and challenges. The listing was part of a long- term plan to implement the best practices in all aspects of our business including R&D, manufacturing, quality control, sales, distribution, finance and corporate governance. In accordance with international laws, standards and past several years has proven valuable for continued and practices, we are becoming a formidable global competitor sustainable growth: R&D and new product launches have and we’re proud to say that customer confidence is at an all been accelerated. The domestic market lead has been time high. Our Initial Public Offering and changes in sustained and further expanded and overseas expansion has management clearly shows that Mindray is serious about been steadily growing. Behind this consistent and substantial every step we take to realizing our vision. growth is our focus on Mindray’s core mission : to produce the finest medical devices at affordable prices, and make them Sustainable growth has always been a major focus for the available to the greatest number of people in China and company, and the foundation we have laid over the worldwide. Mindray Headquarters, High-Tech Industrial Park, Shenzhen, China 1 2 Global Expansion Stockholm Amsterdam Moscow London Frankfurt Toronto Paris Beijing Seattle Milan Istanbul Madrid 29 Branch Offices New Jersey Nanjing Subsidiary company established Cairo New Delhi To be established Mexico City HQ in Shenzhen R&D Center Mumbai R&D Center, Mahwah, NJ, USA Santa Fe de Bogota Jakarta Sao Paulo Global Strategy Broadens Our Vision In 1992, we expanded the playing field by launching the first attained a leading market share in China in terms of number of Mindray’s products has driven healthy sales growth across Pulse Oximeter in the Chinese patient monitoring market. of units sold and total revenues for patient monitoring three major product lines. In 2009 international sales Accelerated Expansion of International Sales Channel Then we developed two other product lines that were firsts in devices. In addition to patient monitoring devices, Mindray contributed 53.9% of the total revenue. In May 2008, a little over a year after the IPO, Mindray took the domestic market: In-Vitro Diagnostic Products and also holds a leading position in China for sales in diagnostic another giant step in global expansion by acquiring the Medical Imaging Systems. In 2000, we entered the laboratory instruments and grey scale ultrasound imaging Mindray's overseas operations have been designed to patient monitoring business of the U.S.-headquartered international market and found that high functionality, top systems sales. facilitate client interaction with our localized team of Datascope Corporation, becoming the third-largest player in quality and superior cost efficiency had proven to be as specialists. This has created a strong bond and forstered the global patient monitoring device industry. popular in the global markets as they were at home. Exposure Mindray has an extensive sales and distribution network client loyalty. Additionally, Mindray has gained greater to the international marketplace has broadened our vision, across thirty major cities to guarantee rapid fulfillment and insight into different cultures, which has increased the Mindray’s integration with Datascope has been seamless and spurred innovation and inspired management. Our dream to maximum customer satisfaction. Along with effective company’s ability to cater to special requirements. we remain on track with our expected synergies. We have and become a world-class developer, manufacturer and marketer customer-oriented R&D and a steady launch of new products, Localization and frequent exposure in industry media and will continue to leverage Datascope's well-established sales of medical devices is now much closer and within our grasp. Mindray’s reliable service is key to helping the company participation in exhibitions such as MEDICA, AACC, ECR and and service channels in the United States and Western Europe sustain growth and expand its market leading position. RSNA, have also enhanced brand awareness in the local to enhance the distribution of Mindray's existing product Market Leader in China markets. lines. Mindray also expects to further benefit from the Mindray is the market leader in China and our products have Rapid International Presence synergies created by combining our strong China-based been used in over 40,000 medical facilities, including At the outset in 2000, Mindray focused on growth in the Reliable quality and competitive pricing have helped engineering and production platforms with Datascope's renowned hospitals like Peking Union Medical College European and North American markets, and has since Mindray to win open bids for public health projects established brands, long-standing reputation for high-quality Hospital and Fudan University Zhongshan Hospital. successfully penetrated over 190 countries and regions. worldwide such as those sponsored by The World Bank and products and service, and both companies' leading R&D According to a Frost &Sullivan report, in 2007 Mindray Worldwide recognition of the quality and cost-effectiveness UNFPA. capabilities. 3 4 Customer Focus Medical professionals employ Mindray products in medical clinics around the world. Mindray employees receive and analyze feedback based on real-life product experiences from diverse medical environments. Customer Demand Enhanced product designs Motivates Innovation come to life in state-of-the-art manufacturing facilities. Customer demand is the source of our innovation, and Overseas subsidiaries contribute greatly to strengthening fulfilling customers' needs is at the heart of Mindray's customer relationships and addressing concerns. Reference corporate values. Our philosophy to create satisfied customers hospitals in different countries also enable us to collect more is reflected throughout all of our operations including R&D, specific concerns and valuable feedback from end users. manufacturing, sales and services. Internally, a unique feedback loop records, sorts and analyzes customer feedback on real-life medically diverse product Healthcare scenarios

Load more

  14

Copy Link